Literature DB >> 18680197

History of medical hospitalization predicts future need for colectomy in patients with ulcerative colitis.

Ashwin N Ananthakrishnan1, Mazen Issa, Dawn B Beaulieu, Sue Skaros, Josh F Knox, Kathryn Lemke, Jeanne Emmons, Sarah H Lundeen, Mary F Otterson, David G Binion.   

Abstract

BACKGROUND: Patients who require hospitalization for the management of ulcerative colitis (UC) may represent a subset with severe disease. These patients may be more likely to require future colectomy. There are limited data examining whether medical hospitalization is predictive of subsequent colectomy.
METHODS: This was a retrospective case-control study utilizing the inflammatory bowel disease center database at our academic referral center. Cases comprised UC patients who underwent colectomy for disease refractory to medical management. The control population was comprised of all patients with UC who had not undergone colectomy. Multivariate logistic regression was used to identify independent predictors of requiring colectomy.
RESULTS: There were a total of 246 UC patients included in our study, with 103 being hospitalized sometime in their disease course (41.9%). A total of 27 patients underwent colectomy (11%). Colectomy patients were significantly more likely to have been on infliximab therapy (51.8% versus 22.4%, P = 0.001) but no more likely to have been on immunomodulator therapy (74.1% versus 59.4%, P = 0.14). Patients who required medical hospitalization for UC were more likely to require future colectomy (20.4% versus 4.2%, P < 0.001) than those who had not required hospitalization. On multivariate analysis, requiring medical hospitalization for management of UC (odds ratio [OR] 5.37, 95% confidence interval [CI] 2.00-14.46) and ever requiring infliximab therapy (OR 3.12, 95% CI 1.21-8.07) were independent predictors of colectomy.
CONCLUSIONS: Requiring medical hospitalization for the management of disease activity in UC is an independent predictor of the need for colectomy. Future studies will determine whether aggressive medical management may modify the need for colectomy in this cohort.

Entities:  

Mesh:

Year:  2009        PMID: 18680197     DOI: 10.1002/ibd.20639

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  14 in total

1.  Long-Term Outcomes of Immunosuppression-Naïve Steroid Responders Following Hospitalization for Ulcerative Colitis.

Authors:  Amar Vedamurthy; Louise Xu; Jay Luther; Francis Colizzo; John J Garber; Hamed Khalili; Ashwin N Ananthakrishnan
Journal:  Dig Dis Sci       Date:  2018-06-27       Impact factor: 3.199

2.  Parameters of a severe disease course in ulcerative colitis.

Authors:  Andreas Stallmach; Luisa Nickel; Thomas Lehmann; Bernd Bokemeyer; Martin Bürger; Dietrich Hüppe; Wolfgang Kruis; Susanna Nikolaus; Jan C Preiss; Andreas Sturm; Niels Teich; Carsten Schmidt
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

3.  Factors That Predict High Health Care Utilization and Costs for Patients With Inflammatory Bowel Diseases.

Authors:  Julajak Limsrivilai; Ryan W Stidham; Shail M Govani; Akbar K Waljee; Wen Huang; Peter D R Higgins
Journal:  Clin Gastroenterol Hepatol       Date:  2016-09-17       Impact factor: 11.382

Review 4.  [Intensive care and inflammatory bowel diseases (IBD). The severe and fulminant flare].

Authors:  J Büning; K Fellermann
Journal:  Internist (Berl)       Date:  2011-07       Impact factor: 0.743

5.  Similar risk of depression and anxiety following surgery or hospitalization for Crohn's disease and ulcerative colitis.

Authors:  Ashwin N Ananthakrishnan; Vivian S Gainer; Tianxi Cai; Raul Guzman Perez; Su-Chun Cheng; Guergana Savova; Pei Chen; Peter Szolovits; Zongqi Xia; Philip L De Jager; Stanley Shaw; Susanne Churchill; Elizabeth W Karlson; Isaac Kohane; Roy H Perlis; Robert M Plenge; Shawn N Murphy; Katherine P Liao
Journal:  Am J Gastroenterol       Date:  2013-01-22       Impact factor: 10.864

6.  Cumulative incidence and risk factors for hospitalization and surgery in a population-based cohort of ulcerative colitis.

Authors:  Sunil Samuel; Steven B Ingle; Shamina Dhillon; Siddhant Yadav; W Scott Harmsen; Alan R Zinsmeister; William J Tremaine; William J Sandborn; Edward V Loftus
Journal:  Inflamm Bowel Dis       Date:  2013-08       Impact factor: 5.325

7.  Adjuvant use of antibiotics with corticosteroids in inflammatory bowel disease exacerbations requiring hospitalisation: a retrospective cohort study and meta-analysis.

Authors:  V Gupta; R Rodrigues; D Nguyen; J Sauk; H Khalili; V Yajnik; A N Ananthakrishnan
Journal:  Aliment Pharmacol Ther       Date:  2015-11-05       Impact factor: 8.171

8.  Total colectomy for ulcerative colitis in children: when are we operating?

Authors:  Jarod P McAteer; Cindy Larison; Ghassan T Wahbeh; Matthew P Kronman; Adam B Goldin
Journal:  Pediatr Surg Int       Date:  2013-04-10       Impact factor: 1.827

Review 9.  Current approaches to the management of new-onset ulcerative colitis.

Authors:  Renée Marchioni Beery; Sunanda Kane
Journal:  Clin Exp Gastroenterol       Date:  2014-05-09

10.  Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases.

Authors:  Joana Torres; Flavio Caprioli; Konstantinos H Katsanos; Triana Lobatón; Dejan Micic; Marco Zerôncio; Gert Van Assche; James C Lee; James O Lindsay; David T Rubin; Remo Panaccione; Jean-Frédéric Colombel
Journal:  J Crohns Colitis       Date:  2016-06-09       Impact factor: 9.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.